http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107119125-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107119125-B |
titleOfInvention | Application of IncRNA-D63785 and interferent thereof and product using IncRNA-D63785 and lncRNA-D63785 |
abstract | The invention provides applications of IncRNA-D63785 and an interferent thereof and a product using the same, and relates to the technical field of medical engineering. The lncRNA-D63785 provided by the invention can be used as a new biomarker for diagnosis and/or prognosis evaluation of gastric cancer; the corresponding interference substance of the lncRNA-D63785 can be used as a novel medicine and has potential prevention and treatment values on various types of gastric cancers. |
priorityDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.